Literature DB >> 8749012

Two-dimensional nondenaturing electrophoresis of lipoproteins: applications to high-density lipoprotein speciation.

C J Fielding1, P E Fielding.   

Abstract

No single technique is able to separate each of the many HDL species present in native plasma. Some are present in only trace proportions. Some HDL have no obvious independent metabolic role, beyond perhaps serving as reservoirs of apoproteins active in metabolic events in other lipoproteins. The choice of HDL analytical technique depends mainly on the problem under study. Two-dimensional nondenaturing electrophoresis has been useful in studies of plasma cholesterol metabolism and cholesterol transport from cells, because it separates intermediates in these processes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8749012     DOI: 10.1016/s0076-6879(96)63017-1

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  4 in total

1.  Domains of apoE4 required for the biogenesis of apoE-containing HDL.

Authors:  Alexander M Vezeridis; Angeliki Chroni; Vassilis I Zannis
Journal:  Ann Med       Date:  2011-06       Impact factor: 4.709

2.  Molecular etiology of a dominant form of type III hyperlipoproteinemia caused by R142C substitution in apoE4.

Authors:  Alexander M Vezeridis; Konstantinos Drosatos; Vassilis I Zannis
Journal:  J Lipid Res       Date:  2010-09-22       Impact factor: 5.922

3.  Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology.

Authors:  B Trigatti; H Rayburn; M Viñals; A Braun; H Miettinen; M Penman; M Hertz; M Schrenzel; L Amigo; A Rigotti; M Krieger
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

4.  The carboxy-terminal region of apoA-I is required for the ABCA1-dependent formation of alpha-HDL but not prebeta-HDL particles in vivo.

Authors:  Angeliki Chroni; Georgios Koukos; Adelina Duka; Vassilis I Zannis
Journal:  Biochemistry       Date:  2007-04-21       Impact factor: 3.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.